Stock VLG VENTURE LIFE GROUP PLC
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Venture Life Group plc

Equities

VLG

GB00BFPM8908

Market Closed - London S.E.
Other stock markets
 11:35:24 2024-04-16 am EDT 		5-day change 1st Jan Change
38.25 GBX -2.55% Intraday chart for Venture Life Group plc +0.66% +14.18%
Apr. 09 Venture Life to benefit from higher prices as profit surges in 2023 AN
Apr. 09 Earnings Flash (VLG.L) VENTURE LIFE GROUP Reports FY23 Revenue GBP51.4M MT

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • The company has a low valuation given the cash flows generated by its activity.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • The company benefits from high valuations in earnings multiples.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Pharmaceuticals

1st Jan change Capi. Investor Rating ESG Refinitiv
VENTURE LIFE GROUP PLC Stock Venture Life Group plc
+14.18% 61.86M -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+28.10% 676B
C+
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.27% 559B
B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.84% 356B
C+
MERCK & CO., INC. Stock Merck & Co., Inc.
+14.71% 320B
B-
ABBVIE INC. Stock AbbVie Inc.
+4.88% 286B
C+
ASTRAZENECA PLC Stock AstraZeneca PLC
+2.62% 213B
B+
NOVARTIS AG Stock Novartis AG
+0.15% 207B
B-
ROCHE HOLDING AG Stock Roche Holding AG
-9.41% 199B
A+
AMGEN INC. Stock Amgen Inc.
-7.77% 142B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. VLG Stock
  4. Ratings Venture Life Group plc